Filed: 11/14/2025ACC: 0001958125-25-000009
📋 What this filing means
CATALIO CAPITAL MANAGEMENT, LP filed this quarterly 13F‑HR report disclosing 38 equity positions with a total reported market value of $540.93M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
38
Positions
$540.93M
Total AUM (reported)
20.43M
Total Shares
Allocation by class
COM$389.49M72.0%
COM NEW$64.58M11.9%
SPONSORED ADS$32.02M5.9%
SPONSORED ADR$28.82M5.3%
SHS$17.56M3.2%
COM STK$6.53M1.2%
COM CL A$992.6K0.2%
Portfolio Concentration
Top 3$111.97M20.7%
4–10$190.60M35.2%
11–25$207.17M38.3%
Rest$31.18M5.8%
Top 3 weight
20.7%
Top 10 weight
55.9%
Voting Authority Distribution
Total shares with voting rights: 20.43M
Sole
Full voting authority
20.43M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole38
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings38
Rows:
ELI LILLY & CO
SOLEShares57.38K
TypeSH
Market value$43.78M
8.09%
Sole
57.38K
Shared
0.00
None
0.00
ABBVIE INC
SOLEShares154.83K
TypeSH
Market value$35.85M
6.63%
Sole
154.83K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares622.73K
TypeSH
Market value$32.34M
5.98%
Sole
622.73K
Shared
0.00
None
0.00
INTUITIVE SURGICAL INC
SOLEShares71.34K
TypeSH
Market value$31.91M
5.90%
Sole
71.34K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares144.95K
TypeSH
Market value$28.82M
5.33%
Sole
144.95K
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares418.25K
TypeSH
Market value$28.27M
5.23%
Sole
418.25K
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares667.62K
TypeSH
Market value$26.27M
4.86%
Sole
667.62K
Shared
0.00
None
0.00
BOSTON SCIENTIFIC CORP
SOLEShares262.97K
TypeSH
Market value$25.67M
4.75%
Sole
262.97K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares1.61M
TypeSH
Market value$24.84M
4.59%
Sole
1.61M
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares451.58K
TypeSH
Market value$24.82M
4.59%
Sole
451.58K
Shared
0.00
None
0.00
NATERA INC
SOLEShares148.37K
TypeSH
Market value$23.88M
4.42%
Sole
148.37K
Shared
0.00
None
0.00
REGENERON PHARMACEUTICALS
SOLEShares35.34K
TypeSH
Market value$19.87M
3.67%
Sole
35.34K
Shared
0.00
None
0.00
STRUCTURE THERAPEUTICS INC
SOLEShares651.81K
TypeSH
Market value$18.25M
3.37%
Sole
651.81K
Shared
0.00
None
0.00
UNIQURE NV
SOLEShares282.94K
TypeSH
Market value$16.52M
3.05%
Sole
282.94K
Shared
0.00
None
0.00
DISC MEDICINE INC
SOLEShares216.53K
TypeSH
Market value$14.31M
2.65%
Sole
216.53K
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares162.14K
TypeSH
Market value$13.77M
2.54%
Sole
162.14K
Shared
0.00
None
0.00
SUPERNUS PHARMACEUTICALS INC
SOLEShares287.09K
TypeSH
Market value$13.72M
2.54%
Sole
287.09K
Shared
0.00
None
0.00
EXACT SCIENCES CORP
SOLEShares248.99K
TypeSH
Market value$13.62M
2.52%
Sole
248.99K
Shared
0.00
None
0.00
PHATHOM PHARMACEUTICALS INC
SOLEShares1.13M
TypeSH
Market value$13.28M
2.46%
Sole
1.13M
Shared
0.00
None
0.00
ADAPTIVE BIOTECHNOLOGIES COR
SOLEShares884.89K
TypeSH
Market value$13.24M
2.45%
Sole
884.89K
Shared
0.00
None
0.00
AVIDITY BIOSCIENCES INC
SOLEShares263.26K
TypeSH
Market value$11.47M
2.12%
Sole
263.26K
Shared
0.00
None
0.00
ADMA BIOLOGICS INC
SOLEShares684.51K
TypeSH
Market value$10.03M
1.86%
Sole
684.51K
Shared
0.00
None
0.00
ULTRAGENYX PHARMACEUTICAL IN
SOLEShares291.26K
TypeSH
Market value$8.76M
1.62%
Sole
291.26K
Shared
0.00
None
0.00
FRACTYL HEALTH INC
SOLEShares5.21M
TypeSH
Market value$8.29M
1.53%
Sole
5.21M
Shared
0.00
None
0.00
GRAIL INC
SOLEShares137.93K
TypeSH
Market value$8.16M
1.51%
Sole
137.93K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ELI LILLY & COSOLE | COM | 57.38K | SH | $43.78M 8.09% | 57.38K | 0.00 | 0.00 |
ABBVIE INCSOLE | COM | 154.83K | SH | $35.85M 6.63% | 154.83K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 622.73K | SH | $32.34M 5.98% | 622.73K | 0.00 | 0.00 |
INTUITIVE SURGICAL INCSOLE | COM NEW | 71.34K | SH | $31.91M 5.90% | 71.34K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 144.95K | SH | $28.82M 5.33% | 144.95K | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COM | 418.25K | SH | $28.27M 5.23% | 418.25K | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 667.62K | SH | $26.27M 4.86% | 667.62K | 0.00 | 0.00 |
BOSTON SCIENTIFIC CORPSOLE | COM | 262.97K | SH | $25.67M 4.75% | 262.97K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 1.61M | SH | $24.84M 4.59% | 1.61M | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 451.58K | SH | $24.82M 4.59% | 451.58K | 0.00 | 0.00 |
NATERA INCSOLE | COM | 148.37K | SH | $23.88M 4.42% | 148.37K | 0.00 | 0.00 |
REGENERON PHARMACEUTICALSSOLE | COM | 35.34K | SH | $19.87M 3.67% | 35.34K | 0.00 | 0.00 |
STRUCTURE THERAPEUTICS INCSOLE | SPONSORED ADS | 651.81K | SH | $18.25M 3.37% | 651.81K | 0.00 | 0.00 |
UNIQURE NVSOLE | SHS | 282.94K | SH | $16.52M 3.05% | 282.94K | 0.00 | 0.00 |
DISC MEDICINE INCSOLE | COM | 216.53K | SH | $14.31M 2.65% | 216.53K | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 162.14K | SH | $13.77M 2.54% | 162.14K | 0.00 | 0.00 |
SUPERNUS PHARMACEUTICALS INCSOLE | COM | 287.09K | SH | $13.72M 2.54% | 287.09K | 0.00 | 0.00 |
EXACT SCIENCES CORPSOLE | COM | 248.99K | SH | $13.62M 2.52% | 248.99K | 0.00 | 0.00 |
PHATHOM PHARMACEUTICALS INCSOLE | COM | 1.13M | SH | $13.28M 2.46% | 1.13M | 0.00 | 0.00 |
ADAPTIVE BIOTECHNOLOGIES CORSOLE | COM | 884.89K | SH | $13.24M 2.45% | 884.89K | 0.00 | 0.00 |
AVIDITY BIOSCIENCES INCSOLE | COM | 263.26K | SH | $11.47M 2.12% | 263.26K | 0.00 | 0.00 |
ADMA BIOLOGICS INCSOLE | COM | 684.51K | SH | $10.03M 1.86% | 684.51K | 0.00 | 0.00 |
ULTRAGENYX PHARMACEUTICAL INSOLE | COM | 291.26K | SH | $8.76M 1.62% | 291.26K | 0.00 | 0.00 |
FRACTYL HEALTH INCSOLE | COM | 5.21M | SH | $8.29M 1.53% | 5.21M | 0.00 | 0.00 |
GRAIL INCSOLE | COM | 137.93K | SH | $8.16M 1.51% | 137.93K | 0.00 | 0.00 |
Page 1 of 2